US 12,285,930 B2
Ophthalmic solution container
Yoshitoh Tanaka, Tokyo (JP); Yuuki Etou, Tokyo (JP); and Toyoaki Suzuki, Tokyo (JP)
Assigned to ZACROS Corporation, Tokyo (JP)
Appl. No. 17/299,704
Filed by Fujimori Kogyo Co., Ltd., Tokyo (JP)
PCT Filed Dec. 6, 2019, PCT No. PCT/JP2019/047969
§ 371(c)(1), (2) Date Jun. 3, 2021,
PCT Pub. No. WO2020/116654, PCT Pub. Date Jun. 11, 2020.
Claims priority of application No. 2018-230193 (JP), filed on Dec. 7, 2018.
Prior Publication US 2022/0055357 A1, Feb. 24, 2022
Int. Cl. B32B 27/08 (2006.01); A61F 9/00 (2006.01); B32B 1/00 (2006.01); B32B 1/02 (2006.01); B32B 27/32 (2006.01); B65D 1/02 (2006.01); B65D 1/08 (2006.01)
CPC B32B 27/08 (2013.01) [A61F 9/0008 (2013.01); B32B 1/00 (2013.01); B32B 27/325 (2013.01); B65D 1/0215 (2013.01); B65D 1/08 (2013.01); B32B 2250/242 (2013.01); B32B 2250/40 (2013.01); B32B 2270/00 (2013.01); B32B 2307/732 (2013.01); B32B 2439/80 (2013.01)] 4 Claims
OG exemplary drawing
 
1. An ophthalmic solution container having an accommodation part in which an ophthalmic solution is accommodated,
wherein the accommodation part is composed of a laminate having an innermost layer that does not contain a cyclic olefin interpolymer (copolymer) and contains a polyethylene resin, an intermediate layer containing a cyclic olefin interpolymer (copolymer) provided outside the innermost layer, and an outer layer containing a polyethylene resin provided outside the intermediate layer containing the cyclic olefin interpolymer (copolymer),
wherein a thickness of the intermediate layer containing the cyclic olefin interpolymer (copolymer) is 50 μm to 1,000 μm, a thickness of the outer layer containing a polyethylene resin is 350 μm to 1,400 μm, a thickness of the innermost layer is 162 μm or less, and a thickness of the laminate is 500 μm to 2,000 μm.